Two Novel Enantiomers from Metarhizium Flavoviride and Their Inhibitory Activities Against Α-Glucosidase

Jie Wei,Cheng Zhao,Guiying Ji,Mei Dong,Ruili Lu,Bo Huang,Guanhu Bao,Fenglin Hu
DOI: https://doi.org/10.1016/j.molstruc.2022.133322
IF: 3.841
2022-01-01
Journal of Molecular Structure
Abstract:A pair of novel enantiomers metarrhiziumoids A (R-enantiomer, 14.3 mg) and B (S-enantiomer, 9.5 mg) were isolated from 3.0 g extract of Metarhizium flavoviride by silica gel column chromatography combined with preparative and semi-preparative HPLC, and identified with high resolution mass, 1D, 2D NMR and circular dichroism. Targets prediction showed that the two compounds had glycosidase inhibitory activity. Result of alpha-glycosidase inhibitory tests showed that the both enantiomers were competitive inhibitors of alpha-glycosidase, and the bioactivity of metarrhiziumoids B (IC50 = 174 mu g/mL) was stronger than that of metarrhiziumoids A (IC50 = 259 mu g/mL). Molecular docking results show that the two enantiomers have different optimal docking modes and the binding energy for the S-enantiomer (-7.8 kcal/mol) was lower than for the R-enantiomer (-7.20 kcal/mol). The docking mode selections and binding energy differences resulted in the inhibitory activity difference. (c) 2022 Elsevier B.V. All rights reserved.
What problem does this paper attempt to address?